1. Georgiadis N, Papamichail D, Lytras T, Halkitis PN, et al.
   The impact of HIV pre-exposure prophylaxis on bacterial sexually transmitted infection occurrence in MSM: A Systematic Review and Meta-analysis.
   AIDS 2024.
   


2. Filip I.
   Liver health matters: targeting modifiable factors to reduce the risk of advanced liver disease in people with HIV.
   AIDS 2024.
   


3. Saura-Lazaro A, Augusto O, Fernandez-Luis S, Lopez-Varela E, et al.
   HIV care retention in three multi-month ART dispensing: a retrospective cohort study in Mozambique.
   AIDS 2024.
   


4. Zhao J, Dong Y, Clark E, Garcia JM, et al.
   Risk and predictors of penile cancer in US Veterans with HIV.
   AIDS 2024.
   


5. Hayashida T, Tran LK, Dang AL, Nagai M, et al.
   Identification of New Circulating Recombinant Form of HIV-1 CRF127_07109 in Northern Vietnam.
   AIDS Res Hum Retroviruses 2024.
   


6. Li W, Feng Y, Han J, Wang X, et al.
   Characterization of two HIV-1 strains with novel unique recombinant genome in Hebei, China.
   AIDS Res Hum Retroviruses 2024.
   


7. Oliva-Sanchez PF, Landeros-Lopez S, Rosas-Dossetti MM, Grobeisen-Levin S, et al.
   Comparison of four predictive scores for cardiovascular risk in Mexican people living with HIV.
   AIDS Res Hum Retroviruses 2024.
   


8. Holt LM, Short WR, Momplaisir F, Hyun E, et al.
   Bictegravir Use During Pregnancy: A Multi-Center Retrospective Analysis Evaluating HIV Viral Suppression and Perinatal Outcomes.
   Clin Infect Dis 2024.
   


9. Tusch E, Ryom L, Pelchen-Matthews A, Mocroft A, et al.
   Trends in mortality in people with HIV from 1999 to 2020: a multi-cohort collaboration.
   Clin Infect Dis 2024.
   


10. Rosenberg NE, Shook-Sa BE, Young AM, Zou Y, et al.
    An HIV-1 risk assessment tool for women aged 15-49 in African countries: A pooled analysis across 15 nationally representative surveys.
    Clin Infect Dis 2024.
    


11. Mwesigwa B, Sawe F, Oyieko J, Mwakisisile J, et al.
    Safety and Immunogenicity of Accelerated Heterologous Two-dose Ebola Vaccine Regimens in Adults With and Without HIV in Africa.
    Clin Infect Dis 2024.
    


12. Whitehill GD, Joy J, Marino FE, Krause RJ, et al.
    Autologous neutralizing antibody responses after antiretroviral therapy in acute and early HIV-1.
    J Clin Invest 2024.
    


13. Gillis N, Dickey BL, Colin-Leitzinger C, Tang YH, et al.
    Clonal hematopoiesis in patients with HIV and cancer.
    J Infect Dis 2024.
    


14. Riddler SA, Kelly CW, Hoesley CJ, Ho KS, et al.
    A Phase 1 Clinical Trial to Assess the Safety and Pharmacokinetics of a Tenofovir Alafenamide/Elvitegravir Insert Administered Rectally for HIV Prevention.
    J Infect Dis 2024.
    


15. Lira GS, Ota VA, Melo MQS, Castineiras ACP, et al.
    Mpox outbreak in Rio de Janeiro, Brazil: A translational approach.
    J Med Virol 2024;96:e29621.
    


16. Li Y, Zhang X, Huang Y, Gao L, et al.
    The prevalence of Human Immunodeficiency Virus infection among voluntary blood donors in mainland China: A systematic review and meta-analysis.
    J Med Virol 2024;96:e29599.
    


17. Persaud AT, Khela J, Fernandes C, Chaphekar D, et al.
    Virion-incorporated CD14 enables HIV-1 to bind LPS and initiate TLR4 signaling in immune cells.
    J Virol 2024.
    


18. Tutlam NT, Kizito S, Liyew TW, Ssewamala FM, et al.
    HIV among refugee youth in Uganda: unmasking the crisis.
    Lancet 2024;403:1536-1537.
    


19. .
    Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990-2021: a sys
    Lancet 2024.
    

Display articles in

• Abstract format
• Medline format